aspire trial myelomapomalidomide multiple myelomaselinexor multiple myelomaisatuximab multiple myelomapomalyst multiple myelomaimmunotherapy in multiple myelomavenetoclax multiple myelomamultiple myeloma organizationssymptomatic multiple myelomamultiple myeloma refractoryamyloidosis in multiple myelomamultiple myeloma supplements